Algorae Pharmaceuticals
(ASX) LCT
Algorae Pharmaceuticals Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$146.21K
Net Income (TTM)
$4.20M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
LCT News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Algorae Pharmaceuticals
Industry
Biotechnology
Sector
Health CareCEO
Bernard E. Tuch, PhD
Website
www.algoraepharma.comHeadquarters
Sydney, NSW 2000, AU
LCT Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-17%
Net Income Margin
-17%
Return on Equity
-62%
Return on Capital
-69%
Return on Assets
-66%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$125.20K
Operating Income
$2.08M
EBITDA
$1.58M
Operating Cash Flow
$1.52M
Capital Expenditure
$0.00
Free Cash Flow
$1.52M
Cash & ST Invst.
$3.11M
Total Debt
$0.00
Algorae Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$125.20K
+7251.7%
Gross Profit
$125.20K
+12941.7%
Gross Margin
100.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$644.47K
+47.3%
EBITDA
$430.37K
-0.8%
Quarterly Fundamentals
Net Cash
$3.11M
-26.7%
Accounts Receivable
$28.97K
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-65.64%
N/A
Return on Invested Capital
-68.93%
N/A
Free Cash Flow
$514.71K
+64.5%
Operating Cash Flow
$514.71K
+64.4%